News & Updates

WellDoc, American Association of Diabetes Educators (AADE) Partner to Incorporate AADE Diabetes Self-Management Education Curriculum into the BlueStar® Digital Therapeutic Platform

January 4, 2017

Col­lab­o­ra­tion Designed to Bring Top Dia­betes Edu­ca­tion Mate­r­i­al into a Dig­i­tal Plat­form to Pro­vide Best-in-Class Con­tent and “Guid­ed Expe­ri­ence” to Indi­vid­u­als Liv­ing with Type 2 Dia­betes

Colum­bia, Mary­land, Jan­u­ary 4, 2017 – Dig­i­tal health leader Well­Doc and lead­ing dia­betes health­care orga­ni­za­tion, the Amer­i­can Asso­ci­a­tion of Dia­betes Edu­ca­tors (AADE), announced today they will part­ner to incor­po­rate the “AADE Dia­betes Edu­ca­tion Cur­ricu­lum: A Guide to Suc­cess­ful Self Man­age­ment” in the BlueS­tar® dig­i­tal ther­a­peu­tic plat­form. BlueS­tar® is an FDA-cleared dig­i­tal ther­a­peu­tic used to help adults liv­ing with type 2 dia­betes self-man­age their con­di­tion.

This part­ner­ship marks the first time AADE, a pro­fes­sion­al mem­ber­ship orga­ni­za­tion com­prised of health­care pro­fes­sion­als from mul­ti­ple dis­ci­plines ded­i­cat­ed to improv­ing dia­betes care through inno­v­a­tive edu­ca­tion, man­age­ment and sup­port, has part­nered with an orga­ni­za­tion to pro­vide its cur­ricu­lum in a con­sumer-friend­ly dig­i­tal for­mat. The cur­ricu­lum, built around the AADE7 Self-Care Behav­iors™, focus­es on the sev­en pri­ma­ry areas of self-man­age­ment: Healthy Eat­ing, Being Active, Mon­i­tor­ing, Tak­ing Med­ica­tion, Prob­lem Solv­ing, Reduc­ing Risks and Healthy Cop­ing.

The dual engage­ment of the per­son with dia­betes and his or her clin­i­cal care team is the core of what makes BlueS­tar a suc­cess­ful tool in help­ing improve out­comes in type 2 dia­betes by reduc­ing A1C for our users,” said Well­Doc Pres­i­dent and CEO Kevin McRaith. “Work­ing with AADE and its mem­ber­ship is both a nat­ur­al and pos­i­tive fit for Well­Doc. The AADE cur­ricu­lum is best-in-class and offer­ing it in a con­sumer friend­ly dig­i­tal for­mat will only fur­ther enhance the val­ue of BlueS­tar.”

As part of this part­ner­ship, AADE and Well­Doc will explore how to col­lec­tive­ly engage AADE’s mem­bers. The orga­ni­za­tions will also look to joint­ly devel­op new strate­gies that bring inno­v­a­tive tools to dia­betes edu­ca­tion and inter­ven­tion through dig­i­tal health chan­nels. BlueS­tar cur­rent­ly pro­vides a plat­form that allows health­care pro­fes­sion­als (includ­ing dia­betes edu­ca­tors and care coor­di­na­tors) to sup­port peo­ple with type 2 dia­betes in between office vis­its.

Dig­i­tal health is a strong com­ple­ment to in-per­son care and edu­ca­tion pro­vid­ed by dia­betes edu­ca­tors. It is ben­e­fi­cial for AADE to lever­age mean­ing­ful part­ner­ships with dig­i­tal health lead­ers, such as Well­Doc, to make every tool avail­able to peo­ple liv­ing with type 2 dia­betes,” said AADE CEO Charles Mac­Far­lane, FACHE, CAE. “Inte­grat­ing our cur­ricu­lum into the BlueS­tar plat­form is an impor­tant strate­gic deci­sion for AADE and will ben­e­fit our mem­bers and peo­ple with type 2 dia­betes in this evolv­ing health­care envi­ron­ment. We look for­ward to con­tin­u­ing to build on this rela­tion­ship.”

About Well­Doc®

Well­Doc is a dig­i­tal health tech­nol­o­gy com­pa­ny that devel­ops mobile solu­tions to dri­ve behav­ioral and clin­i­cal change in chron­ic dis­ease. WellDoc’s goal is to improve patient self-man­age­ment and help physi­cians over­come gaps in the deliv­ery sys­tem to improve clin­i­cal out­comes and decrease cost. Well­Doc has com­mer­cial­ized BlueS­tar®, a dig­i­tal ther­a­peu­tic, for adults with type 2 dia­betes. This ther­a­peu­tic is designed to fill the sup­port gap between patients and providers dur­ing the 8700 hours that indi­vid­u­als live their lives out­side the health­care sys­tem each year. Well­Doc has a proven track record of con­tribut­ing pub­lished, peer-reviewed clin­i­cal evi­dence since 2008 and pre­sent­ed real-world patient engage­ment and clin­i­cal out­comes at the Amer­i­can Dia­betes Association’s (ADA) 76th Sci­en­tif­ic Ses­sions. BlueS­tar® is rec­og­nized by the ADA on its web­site as the first and only in the new class of dia­betes treat­ment known as Mobile Pre­scrip­tion Ther­a­py. In a recent­ly pub­lished Forbes blog, Well­Doc was named among one of five health­care tech com­pa­nies to watch in 2016. For more infor­ma­tion, vis­it and

About Amer­i­can Asso­ci­a­tion of Dia­betes Edu­ca­tors (AADE):

AADE is a mul­ti-dis­ci­pli­nary pro­fes­sion­al mem­ber­ship orga­ni­za­tion ded­i­cat­ed to improv­ing dia­betes care through inno­v­a­tive edu­ca­tion, man­age­ment and sup­port. With more than 14,000 health­care pro­fes­sion­al mem­bers includ­ing nurs­es, dieti­tians, phar­ma­cists, exer­cise spe­cial­ists, and oth­ers, AADE has a vast net­work of prac­ti­tion­ers work­ing with peo­ple who have, are affect­ed by or are at risk for dia­betes. Learn more:

AADE Media Con­tact:
Matt Eaton
Tel: +312.601.4866